Detalhe da pesquisa
1.
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.
Blood Cancer J
; 10(6): 64, 2020 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488055